[Federal Register Volume 85, Number 178 (Monday, September 14, 2020)]
[Notices]
[Page 56633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20162]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-712]


Bulk Manufacturer of Controlled Substances Application: Organix 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Organix Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before November 13, 
2020 Such persons may also file a written request for a hearing on the 
application on or before November 13, 2020.

ADDRESSES:  Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 5, 2020, Organix Inc., 240 Salem Street, 
Woburn, Massachusetts 01801-2029, applied to be registered as a bulk 
manufacturer of the following basic class(es) of a controlled 
substance(s):

------------------------------------------------------------------------
         Controlled substance            Drug code        Schedule
------------------------------------------------------------------------
5-Methoxy-N-N-dimethyltryptamine......        7431  I
------------------------------------------------------------------------

    The company plans to synthesize the above-listed controlled 
substance for distribution to its customers. No other activity for this 
drug code is authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-20162 Filed 9-11-20; 8:45 am]
BILLING CODE P